Evidence map›Paper›PMID 24857021›Full record

ArticleNeuron2014

Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal.

Aya Matsui, Brooke C Jarvie, Brooks G Robinson, Shane T Hentges, John T Williams

Open access · bronzeAbstract read
In one paragraph

Article in Neuron, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 225 citations in OpenAlex.

  1. Article
  2. NAcLat-DBS reduces GABANeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  3. AI-derived therapeutic development of a serotonin receptor-targeting drug for the treatment of opioid use disorder.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Aya MatsuiVollum Institute, Oregon Health and Science University, Portland, OR 97239, USA.
Brooke C JarvieDepartment of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Brooks G RobinsonVollum Institute, Oregon Health and Science University, Portland, OR 97239, USA.
Shane T HentgesDepartment of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
John T WilliamsVollum Institute, Oregon Health and Science University, Portland, OR 97239, USA. Electronic address: williamj@ohsu.edu.
Colorado State University · USOregon Health & Science University · USVollum Institute · US

Funding

COCAINE: EFFECTS ON SINGLE NEURONSR01DA004523 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI WILLIAMS, JOHN T · 1987 to 2025
$7.6M
Ultrastructure and Single Particle Microscopy CoreP30NS061800 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI AICHER, SUE A · 2009 to 2020
$6.6M
Hypothalmic Circuits Regulating Energy Balance and Obesity: Synaptic PhysiologyR01DK078749 · NIDDK · WASHINGTON STATE UNIVERSITY · PI HENTGES, SHANE T · 2008 to 2021
$4.6M
Opioid regulation of hypothalamic neuronsR01DA032562 · NIDA · COLORADO STATE UNIVERSITY · PI HENTGES, SHANE T · 2012 to 2016
$1.6M
Opioid Sensitive GABA inputs to the Ventral MidbrainR01DA034388 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI WILLIAMS, JOHN T · 2012 to 2016
$967k
NIDA NIH HHS DA032562NIDA NIH HHS DA04523NIDA NIH HHS DA34388NIDA NIH HHS R01 DA004523NIDA NIH HHS R01 DA032562NIDA NIH HHS R01 DA034388NIDDK NIH HHS R01 DK078749NINDS NIH HHS P30 NS061800
6 · The paper itself

Abstract

GABA release from interneurons in VTA, projections from the nucleus accumbens (NAc), and rostromedial tegmental nucleus (RMTg) was selectively activated in rat brain slices. The inhibition induced by μ-opioid agonists was pathway dependent. Morphine induced a 46% inhibition of IPSCs evoked from the RMTg, 18% from NAc, and IPSCs evoked from VTA interneurons were almost insensitive (11% inhibition). In vivo morphine treatment resulted in tolerance to the inhibition of RMTg, but not local interneurons or NAc, inputs. One common sign of opioid withdrawal is an increase in adenosine-dependent inhibition. IPSCs evoked from the NAc were potently inhibited by activation of presynaptic adenosine receptors, whereas IPSCs evoked from RMTg were not changed. Blockade of adenosine receptors selectively increased IPSCs evoked from the NAc during morphine withdrawal. Thus, the acute action of opioids, the development of tolerance, and the expression of withdrawal are mediated by separate GABA afferents to dopamine neurons.

Indexed as

Afferent PathwaysAnalgesics, OpioidAnimalsDopaminergic NeuronsDrug ToleranceFemalegamma-Aminobutyric AcidInfusions, IntraventricularMaleOrgan Culture TechniquesRatsRats, Sprague-DawleySubstance Withdrawal SyndromeAnalgesics, Opioidgamma-Aminobutyric Acid

Identifiers

PMID24857021
PMCPMC4072256
OpenAlexW2014708514

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.